Alkem Laboratories Share Price in Focus; Increases Investment to ₹1,036 Crore for Ujjain Facility

 Alkem Laboratories Limited has significantly scaled up its investment plans for a new manufacturing facility in Madhya Pradesh. 

The move reflects the company’s long-term growth strategy and commitment to expanding its production capabilities in the formulations segment. 

Investment Increased for Ujjain Manufacturing Facility 

The company’s Board has approved an increase in the planned investment for its greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh.  

The revised investment now stands at up to ₹1,036 crore, compared to the earlier approved amount of ₹533 crore. 

This increase will be implemented in a phased manner, allowing the company to align capital deployment with project requirements and operational timelines. 

Project Background and Land Allotment 

The development follows an earlier allotment of approximately 30 acres of land at DMIC Vikram Udyogpuri Limited, Phase-2, Ujjain.  

The facility is being established as a greenfield project aimed at enhancing the company’s manufacturing footprint.  

The location is strategically positioned within an industrial corridor, which is expected to support efficient logistics, scalability, and long-term operational efficiency. 

Strategic Expansion and Capacity Building 

The increase in investment indicates Alkem Laboratories’ focus on strengthening its production infrastructure to meet future demand.  

Expanding manufacturing capacity through a greenfield facility allows the company to incorporate modern technologies, improve operational efficiencies, and support product diversification. 

Such investments are also aligned with the broader trend in the pharmaceutical sector, where companies are scaling domestic manufacturing to enhance supply chain resilience and support global market expansion. 

Read More: Alkem Laboratories to Invest ₹533 Crore in New Manufacturing Facility in Ujjain! 

Alkem Laboratories Share Price Performance 

As of 02 April 2026, at 3:30 PM, Alkem Laboratories share price is closed at ₹5,271.00 per share, reflecting a surge of 0.51% from the previous closing price. 

Conclusion 

The decision to increase investment to ₹1,036 crore marks a significant step in Alkem Laboratories’ expansion strategy. The upcoming Ujjain facility is expected to play a key role in strengthening manufacturing capabilities and supporting long-term growth. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.